Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Auctus Biologics
AddedFeb 16, 2024
UpdatedJun 18, 2026
Auctus Biologics

Auctus Biologics

Auctus Biologics: A US-based biotech firm specializing in developing antibody mimetic therapies.

HQ
LaFayette, NY, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Auctus Biologics is a biotechnology company focused on developing antibody mimetic therapies using RPtag-based scaffolds. Their products aim to provide innovative therapeutic and diagnostic solutions, primarily serving the healthcare market in the United States. As a portfolio company of Ichor Therapeutics, Inc., Auctus Biologics leverages advanced biotechnological approaches to address unmet medical needs.

Auctus Biologics has made significant strides in pre-clinical development, positioning itself as a promising player in the biotech industry. The company's affiliation with Ichor Therapeutics underscores its strong foundation and potential for impactful contributions to medical science. Through its innovative approach, Auctus Biologics aims to revolutionize the landscape of antibody mimetic therapies.

Auctus Biologics - Similar Companies

AltruBio logo

AltruBio

ACT Biotech logo

ACT Biotech

ImmuneXcite logo

ImmuneXcite

Actym Therapeutics logo

Actym Therapeutics

actymthera.com

Wave Therapeutics logo

Wave Therapeutics

Marlinspike Therapeutics logo

Marlinspike Therapeutics

A2 Biotherapeutics logo

A2 Biotherapeutics

a2bio.com

Abpro logo

Abpro

NovaXS Biotech logo

NovaXS Biotech

novaxs.co

Aro Biotherapeutics logo

Aro Biotherapeutics

arobiotx.com

Zebra Biologics logo

Zebra Biologics

Attovia Therapeutics logo

Attovia Therapeutics

Abacus Bioscience logo

Abacus Bioscience

BioAegis Therapeutics logo

BioAegis Therapeutics

NXT Biomedical logo

NXT Biomedical

nxtbiomedical.com

Auctus Biologics - Quick Facts

Who are Auctus Biologics' competitors?

Companies similar to Auctus Biologics include AltruBio, ACT Biotech, ImmuneXcite and Actym Therapeutics.

When was Auctus Biologics founded?

Auctus Biologics was founded in 2018.

Where is Auctus Biologics' headquarters located?

Auctus Biologics' headquarters is located in LaFayette, NY, US.

When was Auctus Biologics' last funding round?

Auctus Biologics' most recent funding round was for $228.7k (USD) in February 2022.

How much has Auctus Biologics raised to-date?

As of Feb 9, 2022, Auctus Biologics has raised a total of $1.7M (USD).

How many employees does Auctus Biologics have?

Auctus Biologics has 6 employees as of Feb 4, 2024.

Auctus Biologics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Main Product
  • Antibody Mimetics
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified